compounded semaglutide shortage Out of Shortage, Into Controversy: The Fight Over GLP-1 Compounding Wegovy off shortage list :

Patients should not discontinue statins in favour of GLP-1 therapy for cholesterol management without explicit guidance from their healthcare provider, as this could compromise cardiovascular risk reduction

GLP-1 is a 30 amino acid peptide produced by the L cells, enteroendocrine cells of the distal ileum and colon, and GIP is a 4 amino acid peptide produced by the K cells of the duodenum and jejunum

Generally, you may be a good candidate for GLP-1 therapy if: You have a body mass index (BMI) that falls within a certain range, typically 27 or higher with a weight-related health condition, or 30 or higher without one

The NHS website (nhs.uk) provides patient-facing information on weight management services and referral pathways

Retatrutide is a next-generation triple agonist peptide targeting the GIP (glucose-dependent insulinotropic polypeptide) , GLP-1 (glucagon-like peptide-1) , and glucagon receptors

April 13, 2022